Pharmacology | 1458E396CFD6C991493F257484B551EDA192BD8A

Pharmacology

Name	Pharmacology	DOWNLOAD Copy Link
Total Size	9.0 GB
Total Files	146
Hash	1458E396CFD6C991493F257484B551EDA192BD8A

/Section 4 - CNS Pharmacology/
Pharm01_Raymon_Sec04_Ch01a_SedativeHynoticAnxiolyticDrugs.f4v	311.9 MB
Pharm01_Raymon_Sec04_Ch05a_OpioidAnalgesics.f4v	238.0 MB
Pharm01_Raymon_Sec04_Ch03a_Anticonvulsants.f4v	201.7 MB
Pharm01_Raymon_Sec04_Ch06d_AntipsychoticDrugs.f4v	187.2 MB
Pharm01_Raymon_Sec04_Ch06c_DrugUsedInParkinsonDisease.f4v	152.1 MB
Pharm01_Raymon_Sec04_Ch07a_DrugsUsedInDepression.f4v	149.3 MB
Pharm01_Raymon_Sec04_Ch04a_GeneralAnesthesia.f4v	131.2 MB
Pharm01_Raymon_Sec04_Ch02a_Alcohols.f4v	113.5 MB
Pharm01_Raymon_Sec04_Ch04c_SkeletalMuscleRelaxants.f4v	108.1 MB
Pharm01_Raymon_Sec04_Ch08a_DrugsOfAbuse.f4v	105.1 MB
Pharm01_Raymon_Sec04_Ch04b_LocalAnesthesia.f4v	98.7 MB
Pharm01_Raymon_Sec04_Ch07b_LithiumAndBipolarDisorders.f4v	68.8 MB
Pharm01_Raymon_Sec04_Ch06a_DopaminergicNeuralPathways.f4v	56.5 MB
Pharm01_Raymon_Sec04_Ch07c_DrugsUsedInADHD.f4v	13.6 MB
Pharm01_Raymon_Sec04_Ch06b_DopamineReceptors.f4v	6.2 MB
/Section 5 - Antimicrobial Agents/
Pharm_05_Raymon_Ch01b_InhibCellSynt.f4v	303.5 MB
Pharm_05_Raymon_Ch01c_InhibBactProt.f4v	242.9 MB
Pharm_05_Raymon_Ch01d_InhibiNucACsynth.f4v	113.0 MB
Pharm_05_Raymon_Ch03b_TreatHIV.f4v	104.1 MB
Pharm_05_Raymon_Ch03a_Antitherpetics.f4v	77.7 MB
Pharm_05_Raymon_Ch01a_AntimicroChemo.f4v	51.5 MB
Pharm_05_Raymon_Ch02a_Polynes.f4v	49.2 MB
Pharm_05_Raymon_Ch02c_OthAntifung.f4v	48.1 MB
Pharm_05_Raymon_Ch01f_AntiTBDrugs.f4v	47.6 MB
Pharm_05_Raymon_Ch02b_Azoles.f4v	42.4 MB
Pharm_05_Raymon_Ch03c_FusionInhib.f4v	31.8 MB
Pharm_05_Raymon_Ch04b_Antimalarial.f4v	28.2 MB
Pharm_05_Raymon_Ch03d_OthAntivirals.f4v	27.3 MB
Pharm_05_Raymon_Ch04a_Overview.f4v	23.5 MB
Pharm_05_Raymon_Ch01e_UnclassATB.f4v	22.9 MB
Pharm_05_Raymon_Ch04c_DrugsHelm.f4v	10.8 MB
/Section 2 - Autonomic Pharmacology/
Pharm01_Raymon_Sec02_Ch02b_MuscarinicRecepActivat.f4v	259.7 MB
Pharm01_Raymon_Sec02_Ch04b_ANSPracticeProblems_02.f4v	228.4 MB
Pharm01_Raymon_Sec02_Ch03a_CatecholaminSynActionDegradation.f4v	207.3 MB
Pharm01_Raymon_Sec02_Ch03b_DirectActAdrenoceptorAgonists.f4v	200.1 MB
Pharm01_Raymon_Sec02_Ch02a_CholinericNeuroJunction.f4v	183.7 MB
Pharm01_Raymon_Sec02_Ch01b_BloodPresureConMech.f4v	158.2 MB
Pharm01_Raymon_Sec02_Ch04b_ANSPracticeProblems_01.f4v	136.6 MB
Pharm01_Raymon_Sec02_Ch03e_BetaReceptorAntagonists.f4v	135.2 MB
Pharm01_Raymon_Sec02_Ch01a_AnatomyANS.f4v	113.4 MB
Pharm01_Raymon_Sec02_Ch02c_Muscarinic_RecepAntagonists.f4v	86.0 MB
Pharm01_Raymon_Sec02_Ch01c_PupillarySizeAccomodation_1.f4v	77.0 MB
Pharm01_Raymon_Sec02_Ch03d_AlphaRecepAntagonists.f4v	63.5 MB
Pharm01_Raymon_Sec02_Ch04a_GlaucomaTreatment.f4v	55.9 MB
Pharm01_Raymon_Sec02_Ch02d_NIcotinicRecepAntagonists.f4v	54.2 MB
Pharm01_Raymon_Sec02_Ch03c_IndirectActAdreenergicRecepAgnonists.f4v	42.1 MB
/Section 3 - Cardiac & Renal Pharmacology/
Pharm01_Raymon_Sec03_Ch02a_NA_ChanneLBlockers.f4v	147.1 MB
Pharm01_Raymon_Sec03_Ch04b_Inotropes.f4v	129.2 MB
Pharm01_Raymon_Sec03_Ch01a_CardiacActionPotential.f4v	114.7 MB
Pharm01_Raymon_Sec03_Ch03b_DrugsAlteringSympatheticAct.f4v	103.8 MB
Pharm01_Raymon_Sec03_Ch06d_LoopDiuretics.f4v	103.5 MB
Pharm01_Raymon_Sec03_Ch06c_CarbonicAnhydraseInhibitors.f4v	87.7 MB
Pharm01_Raymon_Sec03_Ch05c_CCBs_BetaBlockers_Carvedilol.f4v	60.3 MB
Pharm01_Raymon_Sec03_Ch03c_DirectActing_Vasodialators.f4v	59.1 MB
Pharm01_Raymon_Sec03_Ch03f_AngiotensinConvertingInhibitors.f4v	58.2 MB
Pharm01_Raymon_Sec03_Ch06a_Diuretics.f4v	57.7 MB
Pharm01_Raymon_Sec03_Ch06e_Thiazides.f4v	55.0 MB
Pharm01_Raymon_Sec03_Ch02e_Unclassified.f4v	54.0 MB
Pharm01_Raymon_Sec03_Ch01b_NA_Channels.f4v	53.4 MB
Pharm01_Raymon_Sec03_Ch04a_TheFailingHeart.f4v	53.3 MB
Pharm01_Raymon_Sec03_Ch02c_K_ChannelBlockers.f4v	48.8 MB
Pharm01_Raymon_Sec03_Ch06f_K_-SparingAgents.f4v	45.3 MB
Pharm01_Raymon_Sec03_Ch05b_Nitrates.f4v	40.9 MB
Pharm01_Raymon_Sec03_Ch03a_DrugsStrategy.f4v	39.9 MB
Pharm01_Raymon_Sec03_Ch07b_HMG-CoA_Reductase_Inhibitors.f4v	37.8 MB
Pharm01_Raymon_Sec03_Ch07a_Antihyperlipidemics.f4v	34.9 MB
Pharm01_Raymon_Sec03_Ch03h_TreatmentOfPulmonaryHyptension.f4v	28.9 MB
Pharm01_Raymon_Sec03_Ch03d_CalciumChannelBlockers.f4v	25.2 MB
Pharm01_Raymon_Sec03_Ch02d_Ca_ChannelBlockers.f4v	23.5 MB
Pharm01_Raymon_Sec03_Ch06b_OsmoticDiuretics.f4v	20.8 MB
Pharm01_Raymon_Sec03_Ch07e_Gemfibrozil.f4v	20.2 MB
Pharm01_Raymon_Sec03_Ch07c_Bile_and_Sequestrants.f4v	17.4 MB
Pharm01_Raymon_Sec03_Ch07d_Nicotine_Acid_Niacin.f4v	14.3 MB
Pharm01_Raymon_Sec03_Ch05a_RationaleForUse.f4v	13.6 MB
Pharm01_Raymon_Sec03_Ch03g_IndicatonsForUseOfAntihypertensive.f4v	11.4 MB
Pharm01_Raymon_Sec03_Ch02b_Beta_Blockers.f4v	11.3 MB
Pharm01_Raymon_Sec03_Ch04C_OtherDrugs.f4v	11.0 MB
Pharm01_Raymon_Sec03_Ch07g_Orlistat.f4v	7.8 MB
Pharm01_Raymon_Sec03_Ch07f_Ezetimbe.f4v	6.5 MB
Pharm01_Raymon_Sec03_Ch03e_Diuretics.f4v	889.5 KB
/Section 1 - General Principles/
Pharm1_Sec01_Ch02b_drCurves.f4v	108.0 MB
Pharm1_Sec01_Ch01b_Permeation.f4v	99.3 MB
Pharm1_Sec01_Ch01e_Biotransformation.f4v	85.9 MB
Pharm1_Sec01_Ch02d_Signaling.f4v	83.1 MB
Pharm1_Sec01_Ch01d_Distribution.f4v	82.5 MB
Pharm1_Sec01_Ch01f_Elimination.f4v	60.9 MB
Pharm1_Sec01_Ch01g_SteadyState.f4v	50.2 MB
Pharm1_Sec01_Ch01c_Absorbtion.f4v	44.0 MB
Pharm1_Sec01_Ch02e_DrugDevelopment.f4v	23.9 MB
Pharm1_Sec01_Ch01a_Pharmokinetics.f4v	17.9 MB
Pharm1_Sec01_Ch02c_Quantal.f4v	17.0 MB
Pharm1_Sec01_Ch02a_Pharmadynamics.f4v	12.0 MB
Pharm1_Sec01_Ch01h_Calculations.f4v	10.4 MB
/Section 6 - Drugs for Inflammatory & Related Disorders/
Pharm_06_Raymon_Ch02a_DrugsGastroDys.f4v	95.5 MB
Pharm_06_Raymon_Ch04e_Nonsteroidal.f4v	74.4 MB
Pharm_06_Raymon_Ch07_Glucco.f4v	68.6 MB
Pharm_06_Raymon_Ch04c_Prostaglandins.f4v	63.1 MB
Pharm_06_Raymon_Ch05_DrugRheumatoid.f4v	53.2 MB
Pharm_06_Raymon_Ch08a_BetaRecept.f4v	43.5 MB
Pharm_06_Raymon_Ch02b_Antiemetics.f4v	40.8 MB
Pharm_06_Raymon_Ch06b_ProphylGout.f4v	40.5 MB
Pharm_06_Raymon_Ch04f_OtherDrugs.f4v	33.9 MB
Pharm_06_Raymon_Ch03a_DrugsSerotonSys.f4v	33.3 MB
Pharm_06_Raymon_Ch01b_H1Antagano.f4v	26.8 MB
Pharm_06_Raymon_Ch01a_Histamine.f4v	23.0 MB
Pharm_06_Raymon_Ch06a_TreatAcuteIn.f4v	21.3 MB
Pharm_06_Raymon_Ch04a_EicosanoidPharm.f4v	15.6 MB
Pharm_06_Raymon_Ch03b_DrugMigraine.f4v	12.7 MB
Pharm_06_Raymon_Ch08e_Glucocort.f4v	10.2 MB
Pharm_06_Raymon_Ch08c_Theo.f4v	10.0 MB
Pharm_06_Raymon_Ch04b_Leukotrienes.f4v	9.3 MB
Pharm_06_Raymon_Ch08d_Cromolyn.f4v	6.2 MB
Pharm_06_Raymon_Ch08b_MuscaRecept.f4v	6.0 MB
Pharm_06_Raymon_Ch04d_Thrombo.f4v	3.3 MB
/Section 7 - Drugs used in Blood Disorders/
Pharm_07_Raymon_Ch01b_HeparinWarfarin.f4v	92.5 MB
Pharm_07_Raymon_Ch02_Thrombo.f4v	47.3 MB
Pharm_07_Raymon_Ch03_Antiplate.f4v	43.7 MB
Pharm_07_Raymon_Ch01a_Overview.f4v	30.8 MB
/Section 8 - Endocrine Pharmacology/
Pharm_08_Raymon_Ch03_Antithy.f4v	57.4 MB
Pharm_08_Raymon_Ch02b_Estrogens.f4v	56.5 MB
Pharm_08_Raymon_Ch01a_Insulins.f4v	48.6 MB
Pharm_08_Raymon_Ch01b_OralHypoglycemics.f4v	41.5 MB
Pharm_08_Raymon_Ch04_HypoPitHormone.f4v	35.1 MB
Pharm_08_Raymon_Ch05a_Biph.f4v	25.5 MB
Pharm_08_Raymon_Ch01e_Thiazolidinediones.f4v	23.7 MB
Pharm_08_Raymon_Ch02e_Androgens.f4v	20.2 MB
Pharm_08_Raymon_Ch02d_OralContra.f4v	19.9 MB
Pharm_08_Raymon_Ch02c_Progestn.f4v	14.4 MB
Pharm_08_Raymon_Ch02a_AdrenalSteroid.f4v	14.0 MB
Pharm_08_Raymon_Ch01f_AgentsAffectingGLP1.f4v	11.5 MB
Pharm_08_Raymon_Ch01c_Metformin.f4v	11.5 MB
Pharm_08_Raymon_Ch01d_Acarbose.f4v	7.4 MB
Pharm_08_Raymon_Ch05b_Terip.f4v	6.1 MB
/Section 11 - Toxicology/
Pharm1_Sec11_Ch01a_CommonToxic.f4v	43.1 MB
Pharm1_Sec11_Ch01b_HeavyMetal.f4v	31.6 MB
Pharm1_Sec11_Ch01c_Antidotes.f4v	14.4 MB
Pharm1_Sec11_Ch01d_NaturalMed.f4v	12.6 MB
/Section 9 - Anticancer Drugs/
Pharm1_Sec09_Ch01b_Drugs.f4v	37.4 MB
Pharm1_Sec09_Ch01a_Princ_Def.f4v	25.3 MB
Pharm1_Sec09_Ch01c_Toxicity.f4v	13.3 MB
Pharm1_Sec09_Ch01d_Resistence.f4v	12.0 MB
/Section 10 - Immunopharmacology/
Pharm_10_Raymon_Ch01d_Monoclonal.f4v	16.2 MB
Pharm_10_Raymon_Ch01a_Cyclosporine.f4v	14.6 MB
Pharm_10_Raymon_Ch01e_Cytokines.f4v	6.0 MB
Pharm_10_Raymon_Ch01c_AntiDImmunol.f4v	4.1 MB
Pharm_10_Raymon_Ch01b_Azathioprine.f4v	3.7 MB
Total files 146